Avalo Therapeutics (AVTX) Operating Margin Growth (3y) (2019 - 2025)
Avalo Therapeutics (AVTX) Operating Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Avalo Therapeutics | 395.30 Mn | 338.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.25 Mn |
| Dec 31, 2024 | 126,947.00 |
| Sep 30, 2024 | -394,558.00 |
| Dec 31, 2023 | -24,971.00 |
| Sep 30, 2023 | -39,393.00 |
| Jun 30, 2023 | -22,894.00 |
| Mar 31, 2023 | -71,032.00 |
| Dec 31, 2022 | -84,511.00 |
| Sep 30, 2022 | 15,739.00 |
| Jun 30, 2022 | -96,301.00 |
| Mar 31, 2022 | -158,349.00 |
| Dec 31, 2021 | -822,696.00 |
| Sep 30, 2021 | -62,284.00 |
| Jun 30, 2021 | -39,033.00 |
| Mar 31, 2021 | -638,136.00 |
| Dec 31, 2020 | -86,345.00 |
| Sep 30, 2020 | -128,260.00 |
| Jun 30, 2020 | 24,180.00 |
| Mar 31, 2020 | -64,633.00 |
| Dec 31, 2019 | 78,339.00 |